CARTILAGE PERICHONDRIUM COMPOSITE GRAFT TYMPANOPLASTY OUTCOMES IN PATIENTS WITH PERSISTENT SUPPURATIVE OTITIS MEDIA

Authors

  • Dr. Shib Shankar Paul Author
  • Dr. Alaknanda Debnath Author

Keywords:

AB gap closure, cartilage-perichondrium, composite graft, CSOM, tympanic membrane, tympanoplasty

Abstract

Background: For the reconstruction of atelectatic and recurring tympanic membrane perforations, cartilage-
perichondrium composite grafts are the preferred material. The available literature on this topic, however, is lacking in
detail.
Aim: The purpose of the current study was to evaluate the results and effectiveness of tympanic membrane perforation
individuals' cartilage-perichondrium composite graft tympanoplasty. The research also assessed the success rates of
tympanic membrane closure, postoperative hearing results, and comorbidities.
Methods: During the research period, 220 participants who had been treated with cartilage-perichondrium composite
graft tympanoplasty for chronic suppurative otitis media (CSOM) were evaluated clinically. The effectiveness, results,
complications, postoperative hearing outcomes, and success rates of tympanic membrane closure were evaluated in
relation to the data.
Results: The study individuals' total graft ingestion was 99.09%. An air-bone closure of up to 20dB was obtained in
86.11%, 72.22%, and 70.58% of research individuals after type I, type II, and type III tympanoplasty, respectively. A
socially acceptable hearing threshold of 30 dB or below was attained by 97.26% of the participants undergoing various
tympanoplasty procedures.
Conclusion: The results of this study indicate that the cartilage-perichondrium composite graft is a dependable and
effective method for closing tympanic membrane holes. Excellent closure rates and better hearing outcomes from this
treatment increase the participants' quality of life.

Downloads

Published

16-09-2022

How to Cite

CARTILAGE PERICHONDRIUM COMPOSITE GRAFT TYMPANOPLASTY OUTCOMES IN PATIENTS WITH PERSISTENT SUPPURATIVE OTITIS MEDIA. (2022). International Research Journal of Pharmacy, 13(9), 23-26. https://irjponline.org/index.php/irjp/article/view/400